drugset / Trial / NCT05946798

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

NCT05946798

Phase 0 Recruiting 40 enrolled Anna Stanhewicz, PhD
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this investigation is to examine NADPH oxidase as a source of reactive oxygen species contributing to aberrant microvascular function in otherwise healthy women with a history of GDM.

Timeline

Start
2023-08-30
Primary completion
2027-06-30
Completion
2028-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcholine Small molecule Other
Subject insulin aspart Protein / enzyme biologic Other

Indications